[email protected]

国际临床研究杂志

International Journal of Clinical Research

您当前位置:首页 > 精选文章

International Journal of Clinical Research. 2025; 9: (3) ; 10.12208/j.ijcr.20250134 .

Clinical comparative study of different doses of nalbuphine combined with lidocaine in propofol based gastrointestinal endoscopy
不同剂量纳布啡复合利多卡因应用于以丙泊酚为基础的消化内镜检查的临床对比研究

作者: 金英红 *

浙江省东阳市妇幼保健院 浙江东阳

*通讯作者: 金英红,单位:浙江省东阳市妇幼保健院 浙江东阳;

引用本文: 金英红 不同剂量纳布啡复合利多卡因应用于以丙泊酚为基础的消化内镜检查的临床对比研究[J]. 国际临床研究杂志, 2025; 9: (3) : 78-80.
Published: 2025/3/29 10:20:08

摘要

目的 分析不同剂量纳布啡复合利多卡因应用于以丙泊酚为基础的消化内镜检查的临床对比差异。方法 选取2024年3月至2025年1月到医院行无痛消化内镜检查(先做胃镜后做结肠镜)患者当作研究对象,入选对象共300例,依照药物剂量作为分组原则,分为A组(静脉注射纳布啡0.05mg/kg+利多卡因0.5mg/kg)、B组(静脉注射纳布啡0.1mg/kg+利多卡因0.5mg/kg)、C组(静脉注射纳布啡0.5mg/kg)、D组(静脉注射纳布啡0.1mg/kg)、E组(静脉注射利多卡因0.5mg/kg)、F组(静脉注射生理盐水),每组50例。对比六组的丙泊酚引起注射痛严重程度及不良反应发生率。结果 在丙泊酚引起注射痛分级上,B组优于A组、C组、D组、E组、F组(P<0.05)。在并发症发生率上,B组低于A组、C组、D组、E组、F组(P<0.05)。结论 0.1mg/kg纳布啡+0.5mg/kg利多卡因用于以丙泊酚为基础的消化内镜检查的效果良好,有助于减轻丙泊酚引起注射疼痛程度,减少不良反应的发,临床可进一步推广应用。

关键词: 消化内镜检查;纳布啡复合利多卡因;丙泊酚引起注射痛;不良反应发生率

Abstract

Objective To analyze the clinical comparative differences of different doses of nalbuphine combined with lidocaine in propofol based gastrointestinal endoscopy.
Methods A total of 300 patients who underwent painless digestive endoscopy (gastroscopy followed by colonoscopy) at the hospital from March 2024 to January 2025 were selected as the study subjects. According to the principle of drug dosage, they were divided into Group A (intravenous injection of nalbuphine 0.05mg/kg+lidocaine 0.5mg/kg), Group B (intravenous injection of nalbuphine 0.1mg/kg+lidocaine 0.5mg/kg), Group C (intravenous injection of nalbuphine 0.5mg/kg), Group D (intravenous injection of nalbuphine 0.1mg/kg), Group E (intravenous injection of lidocaine 0.5mg/kg), and Group F (intravenous injection of physiological saline), with 50 patients in each group. Compare the severity of injection pain and incidence of adverse reactions caused by propofol in six groups.
Results In terms of pain grading caused by propofol injection, Group B was superior to Group A, C, D, E, and F (P<0.05). In terms of the incidence of complications, Group B was lower than Group A, C, D, E, and F (P<0.05).
Conclusion   The use of 0.1 mg/kg nalbuphine and 0.5 mg/kg lidocaine for propofol based gastrointestinal endoscopy is effective in reducing injection pain caused by propofol and minimizing the occurrence of adverse reactions. It can be further promoted and applied in clinical practice.

Key words: Digestive endoscopy examination; Nabufine combined with lidocaine; Propofol causes injection pain; Adverse reaction incidence rate

参考文献 References

[1] 尹晓俊.瑞马唑仑联合纳布啡在无痛胃肠镜检查中的麻醉效果[J].中国药物与临床,2024,24(5):310-313.

[2] 陆叶兰,林家燕,周诚忠.丙泊酚分别复合地佐辛和纳布啡在胃癌患者无痛胃镜检查中的应用比较[J].肿瘤基础与临床,2023,36(5):426-428.

[3] 杨慧,刘德杰.探究纳布啡+丙泊酚+依托咪酯麻醉用于老年患者无痛胃肠镜检查的麻醉效果[J].系统医学,2024, 9(1): 33-36.

[4] 郝守则,李子玮.右美托咪定复合丙泊酚和纳布啡对老年无痛胃镜检查患者认知功能的影响观察[J].药物流行病学杂志,2022,31(02):83-87+100.

[5] 霍奇帆,赵静,郭建伟,等.纳布啡对插入喉罩时最低丙泊酚有效血浆质量浓度的影响[J].西北药学杂志,2022,37(4): 117-121.

[6] 谢本发,牛居辉,何睿,等.纳布啡在无痛胃肠镜检查中减轻丙泊酚静脉注射痛的效果[J].中国内镜杂志,2023,29(7):5-19.

[7] 王颖科.不同剂量纳布啡复合丙泊酚在门诊无痛胃肠镜检查中的应用效果[J].河南医学研究,2023,32(2):278-281.

[8] 韦炳耐,马凯宇,旷昕,等.纳布啡与舒芬太尼复合丙泊酚麻醉诱导对宫腔镜手术患者脑电双频指数及麻醉复苏影响[J].中国计划生育学杂志,2023,31(3):570-574.